Waterlooville man who lost his wife to bowel cancer welcomes research breakthrough
A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...
New bowel cancer test shows greater than 90% accuracy in high-risk patients
Experts hope to create a blood test to see which patients with inflammatory bowel disease are most at risk of bowel cancer.
Groundbreaking new test 90% accurate in finding patients at high risk of bowel cancer
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
gastroenterologyadvisor21h
Severe Histologic Disease Activity in UC Raises Risk of Biologic-Associated Colectomy
Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.
Palisade Bio Selected for Poster Presentation at the 2025 Crohn’s & Colitis Congress
Carlsbad, CA, Jan. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel ...
Ibj.com22h
Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment
The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...